DGDongchuan Guo

Dongchuan Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dongchuan Guo has a total of 250 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Loss-of-function variants in ADAMTS6: A new connective tissue disorder with heart defect, aortic aneurysm, and neurodevelopmental features

    by Júlia Huguet Herrero, Pauline Arnaud, Angelique Bibimbou, Deborah E. Seifert, Zakaria Mougin, Louise Benarroch, Caroline Michot, Yline Capri, Lyse Ruaud, Sophie Dupuis-Girod, et al.

  • Top Cited Papers

    Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve

    by Sébastien Thériault, Jacob A. Holdcraft, Dinara Sharipova, Adèle Faucherre, Radoslaw M. Debiec, Gina M. Peloso, Baravan Al-Kassou, Sary Aranki, Elena Ashikhmina Swan, Andrea Ballotta, et al.

    BACKGROUND: Bicuspid aortic valve (BAV) is a frequent congenital heart defect with a high heritability. Despite this, only a limited number of genes have been associated with the disease, and the molecular mechanisms remain unexplained in most cases. This study aimed to further understand the genetic architecture of BAV. METHODS: A genome-wide association study meta-analysis including 9631 cases among 65 677 participants was performed. Genes were prioritized using transcriptomic analyses based on RNA sequencing in relevant tissues, including human fetal and adult aortic valves. The impact of the knockdown or knockout of 4 candidate genes on cardiac development was verified in zebrafish. A polygenic risk score was developed, its association with BAV was evaluated in an independent cohort, and its association with a wide range of phenotypes (n=976) was evaluated in UK Biobank (n=355 618 individuals). RESULTS: Thirty-six genomic loci were identified, including 32 that were not described previously. Among the prioritized genes, KANK2 and ERBB4 were identified as potentially causal through transcriptomic analyses, colocalization, and Mendelian randomization based on gene expression in human aortic valves (n=484), whereas PRDM6 and STRN were prioritized using similar analyses from aortic (n=326) and left ventricular tissues (n=326), respectively. Targeting 4 candidate genes ( WNT4 , LEF1 , STRN , and KANK2 ) in zebrafish led to disruption in cardiac development. A polygenic risk score was associated with an odds ratio of 2.07 (95% CI, 1.90–2.25; P =5.43×10 -62 ) per SD for BAV and significantly associated with thoracic aortic aneurysm and atrial fibrillation in UK Biobank. CONCLUSIONS: This study supports a significant polygenic contribution to BAV, where the combination of multiple common variants in genes involved in heart morphogenesis disrupts aortic valve development.


  • Open Access

    Bicuspid Aortic Valve in Heritable Thoracic Aortic Disease: Insights from the Montalcino Aortic Consortium

    by Kishan L. Asokan, Neha Muraly, Dongchuan Guo, Deep M. Shah, Ernesto C. Martinez, Elena Cervi, Julie De Backer, Laura Muiño Mosquera, Wannes Renders, Alan C. Braverman, et al.

    Bicuspid aortic valve (BAV) is the most common congenital heart malformation and predisposes to thoracic aortic aneurysms. The Montalcino Aortic Consortium (MAC) registry collects genetic and phenotypic data on individuals with heritable thoracic aortic disease genes (HTAD PVs) that primarily regulate smooth muscle cell contraction or TGF-β signaling (TGF-β PVs, termed Loeys-Dietz Syndrome (LDS)). We evaluated associations between BAV, HTAD PVs and aortic outcomes in the MAC cohort. BAV was present in 48 (6%) of 816 MAC participants (age 38 [IQR 20-52] years, 51% female) and was not significantly increased in males or in the entire TGF-β PV group (417 with TGF-β PVs, p=0.14) but was enriched in participants with TGFBR1 or TGFBR2 PVs (16/168, 10% vs. 32/648, 5%, PR 1.93 [1.08, 3.43], pP< 0.001), younger age at first aortic event (24 vs. 40 years, p0.5). Sinus of Valsalva dilation (Z>3, 25/48, 52% vs. 128/768, 17%, P< 0.0001) and ascending aorta dilation (Z>3, 12/48, 25% vs. 26/768, 3%, P< 0.0001) were more common in participants with BAV. Participants with both TGF-β PV and BAV more frequently had aortic valve surgery (17/30, 57% vs. 110/387, 28%, PR 1.99 [1.40-2.83], pLDS TGFBR1 and TGFBR2 , and is associated with accelerated aortic valve and aortic diseasebut does not confer an increased risk for aortic dissection. These observations highlight the potential benefits of genetic testing for BAV patients who have a family history of HTAD, a sinus of Valsalva aneurysm, or clinical features suggestive of LDS.


  • Dissecting the Genetic Architecture of Intracranial Aneurysms

    by Shaunak S. Adkar, Julie Lynch, Ryan B. Choi, Tanmoy Roychowdhury, Renae L. Judy, Kaavya Paruchuri, Dong-Chuan Go, Sharika Bamezai, John Cabot, Sabina Sorondo, et al.

    BACKGROUND: The genetic risk of intracranial aneurysm (IA) development has been ascribed to the genetic risk of smoking exposure and hypertension. The relationship of IA to other cardiovascular traits and the contribution of IA risk loci to aberrant gene programs within cerebrovascular cell types remains unclear. METHODS: We performed a genome-wide association study in the Million Veteran Program and Finnish cohort study testing association of roughly 25 million DNA variants with unruptured IA (4694 cases and 877 091 controls) in individuals of European, African, and Hispanic ancestries. Meta-analysis with publicly available summary statistics generated a final cohort of 15 438 cases and 1 183 973 controls. We constructed a cerebrovascular single-nuclear RNA sequencing data set and integrated IA summary statistics to prioritize candidate causal cell types. We constructed a polygenic risk score to identify patients at risk of developing IA. RESULTS: We identified 5 novel associations with IA, increasing the number of known susceptibility loci to 22. At these susceptibility loci, we prioritized 17 candidate causal genes. We found a significant positive genetic correlation of IA with coronary artery disease and abdominal aortic aneurysm. Integration of an IA gene set with cerebrovascular single-nuclear RNA sequencing data revealed a significant association with pericytes and smooth muscle cells. Finally, a polygenic risk score was significantly associated with IA across European (odds ratio, 1.87 [95% CI, 1.61–2.17]; P =8.8×10 − 17 ), African (odds ratio, 1.62 [95% CI, 1.19–2.15]; P =1.2×10 − 3 ), and Hispanic (odds ratio, 2.28 [95% CI, 1.47–3.38]; P =1.0×10 − 4 ) ancestries. CONCLUSIONS: Here, we identify 5 novel loci associated with IA. Integration of summary statistics with cerebrovascular single-nuclear RNA sequencing reveals an association of cell types involved in matrix production. We validated a polygenic risk score that predicts IA, controlling for demographic variables including smoking status and blood pressure. Our findings suggest that a deficit in matrix production may drive IA pathogenesis independent of hypertension and smoking.


  • Open Access

    Genome-First Approach to Rare and Common Variant Risk of Thoracic Aortic Aneurysm and Dissection

    by John DePaolo, Diane T. Smelser, Dongchuan Guo, Sarah Abramowitz, Gina Sisti, Renae Judy, Nimesh Desai, Wilson Y. Szeto, Michael G. Levin, Hannah Mirshahi, et al.

    Background: Thoracic aortic aneurysm and dissection (TAAD) can have catastrophic health consequences. Eleven genes have strong or definitive evidence for causing heritable TAAD (HTAAD). However, patients are seldom tested for rare pathogenic (P) or likely pathogenic (LP) variants in these HTAAD genes absent a strong family history or syndromic features, and little is known about either their prevalence in the general population or the associated TAAD risk. Furthermore, the degree to which common genetic variation associated with TAAD modifies rare variant pathogenicity is unknown. Methods: Penn Medicine Biobank (PMBB) and MyCode participants volunteered to have electronic health records linked to biospecimen data including DNA which has undergone genome-wide genotyping and whole exome sequencing. P/LP HTAAD gene variants were adjudicated according to American College of Medical Genetics and Genomics standards, and logistic regression was performed to determine the associated risk of prevalent TAAD. An ascending aortic diameter (AscAoD) polygenic risk score (PRS) was derived from a genome-wide association study (GWAS) of aortic diameter to assess common variant TAAD risk, and regression analyses were performed to determine the modifying effect this PRS had on penetrance of rare variants. Results: Across the two analytic cohorts, 0.2-0.3% of participants carried a P/LP HTAAD gene variant. Compared to individuals without a P/LP variant, carrying a P/LP HTAAD variant was associated with a 13.5-fold increased risk of a diagnosis of TAAD (95% confidence interval [CI] 5.3 to 34.6, P P P <0.01) suggesting that common variant risk may be an important modifier of rare variant risk for TAAD. Conclusions: Our results indicate that P/LP HTAAD gene variants confer a significant increased risk of TAAD in the population at-large, and that polygenic risk may be an important modifier of rare variant risk.


  • Aortic and arterial manifestations and clinical features inTGFB3-related heritable thoracic aortic disease: results from the Montalcino Aortic Consortium

    by Michelle Su-Anne Lim, Dong-Chuan Guo, Walter Velasco Torrez, Andrew Lai, Jonathan Schweber, Nikita Garg, Julie Fleischer, Catherine Boileau, Julie De Backer, Artur Evangelista, et al.

    Background: Pathogenic variants inTGFB3may lead to a syndromic genetic aortopathy. Heritable thoracic aortic disease (HTAD) and arterial events may occur inTGFB3-related disease but there are limited outcomes data on vascular events in this condition.Methods: Clinical data, phenotypical features and aortic outcomes in individuals with pathogenic/likely pathogenic (P/LP)TGFB3variants enrolled in the Montalcino Aortic Consortium registry were reviewed.Results: 34 individuals (56% male, median age 42 years, IQR 17–49, range 3–74 years) with P/LPTGFB3variants were studied. Craniofacial, cutaneous and musculoskeletal features seen in Loeys-Dietz syndrome were variably present. Extra-aortic cardiovascular features included arterial tortuosity (25%), extra-aortic arterial aneurysms (6%) and mitral valve prolapse (21%).Aortic dilation (Z-Score>2) was present in 10 individuals (29%) and aortic dissection occurred in 2 (6%). Type A aortic dissection occurred in two patients (aged between 55 years and 60 years), and one of these patients experienced a type B aortic dissection 6 years later. Seven adults (median age 62 years, range 32–69 years) with aortic root dilation (41–49 mm) are being followed. No patients have undergone prophylactic aortic surgery. Twenty-five per cent of children have aortic dilation. Sixty-eight per cent of the entire cohort remains free of aortic disease. No deaths have occurred.Conclusions: TGFB3-related HTAD is characterised by late-onset and less penetrant thoracic aortic and arterial disease compared with other transforming growth factor β HTAD. Based on our data, a larger aortic size threshold for prophylactic aortic surgery is appropriate in patients withTGFB3-related HTAD compared with HTAD due toTGFBR1orTGFBR2variants.


  • Whole-exome sequencing uncovers the genetic complexity of bicuspid aortic valve in families with early-onset complications

    by Sara Mansoorshahi, Anji T. Yetman, Malenka M. Bissell, Yuli Y. Kim, Hector I. Michelena, Julie De Backer, Laura Muiño Mosquera, Dawn S. Hui, Anthony Caffarelli, Maria G. Andreassi, et al.


  • Open Access

    Bicuspid Aortic Valve Disease with Early-Onset Complications: Characteristics and Aortic Outcomes

    by Maximilian A. Selbst, Colin R. Ward, Megan L. Svetgoff, Hector I. Michelena, Anna Sabate-Rotes, Julie De Backer, Laura Muiño Mosquera, Anji T. Yetman, Malenka M. Bissell, Maria Grazia Andreassi, et al.

    Bicuspid aortic valve (BAV) is the most common congenital heart malformation in adults, but it can also cause childhood-onset complications. The presentation and clinical course of young adults who present due to BAV complications are relatively uncharacterized. In a multicenter study, we found that young people who experience significant complications related to BAV disease before age 30 are distinguished from the majority of BAV cases that manifest after age 50 by a relatively severe clinical course, with higher rates of surgical interventions, more frequent second interventions, and a greater burden of congenital heart malformations. These observations highlight the need for prompt recognition, regular lifelong surveillance, and targeted interventions to address the significant health burdens of patients with early-onset BAV complications.


  • Top Cited Papers
    Open Access

    Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program

    by Derek Klarin, Poornima Devineni, Anoop K. Sendamarai, Anthony R. Angueira, Sarah E. Graham, Ying H. Shen, Michael G. Levin, James P. Pirruccello, Ida Surakka, Purushotham R. Karnam, et al.

    The current understanding of the genetic determinants of thoracic aortic aneurysms and dissections (TAAD) has largely been informed through studies of rare, Mendelian forms of disease. Here, we conducted a genome-wide association study (GWAS) of TAAD, testing ~25 million DNA sequence variants in 8,626 participants with and 453,043 participants without TAAD in the Million Veteran Program, with replication in an independent sample of 4,459 individuals with and 512,463 without TAAD from six cohorts. We identified 21 TAAD risk loci, 17 of which have not been previously reported. We leverage multiple downstream analytic methods to identify causal TAAD risk genes and cell types and provide human genetic evidence that TAAD is a non-atherosclerotic aortic disorder distinct from other forms of vascular disease. Our results demonstrate that the genetic architecture of TAAD mirrors that of other complex traits and that it is not solely inherited through protein-altering variants of large effect size.


  • An FBN1 deep intronic variant is associated with pseudoexon formation and a variable Marfan phenotype in a five generation family

    by Dong‐Chuan Guo, Xueyan Duan, Kathleen Mimnagh, Alana C. Cecchi, Isabella C. Marin, Yang Yu, Walter V. Velasco, Kwanghyuk Lee, Xue Zhu, David R. Murdock, et al.

    Exome sequencing of genes associated with heritable thoracic aortic disease (HTAD) failed to identify a pathogenic variant in a large family with Marfan syndrome (MFS). A genome‐wide linkage analysis for thoracic aortic disease identified a peak at 15q21.1, and genome sequencing identified a novel deep intronic FBN1 variant that segregated with thoracic aortic disease in the family (LOD score 2.7) and was predicted to alter splicing. RT‐PCR and bulk RNA sequencing of RNA harvested from fibroblasts explanted from the affected proband revealed an insertion of a pseudoexon between exons 13 and 14 of the FBN1 transcript, predicted to lead to nonsense mediated decay (NMD). Treating the fibroblasts with an NMD inhibitor, cycloheximide, greatly improved the detection of the pseudoexon‐containing transcript. Family members with the FBN1 variant had later onset aortic events and fewer MFS systemic features than typical for individuals with haploinsufficiency of FBN1. Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies.